24/7 Market News Snapshot 06 January, 2025 – SciSparc Ltd. Ordinary Shares (NASDAQ:SPRC)

January 6, 2025

DENVER, Colo., 06 January, 2025 (247marketnews.com) – (NASDAQ:SPRC) are discussed in this article.
SciSparc Ltd. (SPRC) is generating considerable excitement as its share price surges to $1.213 in pre-market trading, representing an impressive increase of 129.78% from the previous close of $0.528. This remarkable uptick is accompanied by a significant trading volume of 13.78 million shares, indicating heightened investor interest and confidence in the company’s prospects. Technical analysis suggests a strong upward trajectory, raising the anticipation among traders for continued gains as the market opens.

In a strategic move underscoring its commitment to advancing therapeutic development, SciSparc has strengthened its collaboration with Clearmind Medicine Inc. This partnership has reached a crucial milestone with the publication of a European patent application by Clearmind, focused on a novel combination therapy that targets binge behaviors such as alcohol consumption and impulsive actions. The patent highlights the potential of integrating MEAI and N-Acylethanolamines, positioning this innovative approach at the forefront of addressing critical mental health challenges.

The collaboration has already yielded the successful filing of thirteen patents across various jurisdictions, demonstrating both companies’ dedication to pioneering therapeutic options for under-treated conditions. SciSparc, recognized for its expertise in cannabinoid pharmaceuticals, is actively advancing multiple development programs targeting significant neurological disorders, including Tourette Syndrome, Alzheimer’s Disease, and autism.

Clearmind, known for its innovative psychedelic-derived therapeutics aimed at addressing widespread health issues, brings an extensive intellectual property portfolio consisting of nineteen patent families to this alliance. With both companies poised to continue exploring new growth opportunities, their partnership represents a promising avenue for medical advancement, significantly impacting the treatment landscape for mental health disorders and improving the quality of life for countless individuals.

Related news for (SPRC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.